Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Accumulated amortization of deferred leasing costs	$ 41,846	$ 41,448
Common shares of beneficial interest, par value (in dollars per share)	$ 0.01	$ 0.01
Common shares of beneficial interest, shares authorized (in shares)	150,000,000	150,000,000
Common shares of beneficial interest, shares issued (in shares)	112,640,861	112,555,352
Common shares of beneficial interest, shares outstanding (in shares)	112,640,861	112,555,352
Investing Receivables
Investing receivable allowance for credit loss	$ 2,361	$ 2,377